after intracerebral inoculation exacerbated an inapparent infection, leading to paralysis in eight of nine and death in six of nine Wistar Furth test rats. In such immunosuppressed animals, grey-and white-matter lesions were noted throughout the central nervous system, in contrast to the purely demyelinating lesions noted previously. Since rats, unlike mice, were not susceptible to disease after intracerebral injection with the serorelated viscerotropic strain MHV-3, we wished to extend our understanding of the neurological disease process elicited by the two viruses in rodents. For this reason, various mouse strains, including some with recognized immunodeficiencies, were challenged by different routes of inoculation. Intraperitoneal infection of nude and beige mice with JHMV indicated that lack of natural killer cell functions does not markedly enhance the susceptibility to virus, whereas T-cell activity appears to be essential for resisting infection. JHMV and MHV-3 replication in peritoneal macrophages from highly resistant A/J mice was reduced in comparison with that noted in macrophages from susceptible C57BL6/J mice. An initial intraperitoneal inoculation of JHMV was able to protect C57BL6/J mice against fatal intracerebral challenge within 3 days, whereas A/J mice remained susceptible beyond day 3. The protective effect did not appear to result from increased levels of circulating interferon, preceded elevation in serum JHMV-neutralizing antibody titers, and persisted for at least several weeks after intraperitoneal inoculation. Based on the combined studies described here and on previous work by us and others, it appears that the factors influencing the outcome of coronavirus disease in rodents are age at inoculation, route of challenge, genetic constitution of the virus and host, and competence of the immune system, particularly cellular immunity involving T-cells.
FACTORS INFLUENCING DISEASE CAUSED BY MHV 1249
there developes an age-related resistance to hepatic disease within the first 3 months of life (13) . However, these strains may become paralyzed and manifest lesions in the central nervous system (CNS) several months after intraperitoneal (i.p.) inoculation of Conceming the influence of the immune system, nude mice or other strains which have been thymectomized or immunosuppressed (4, 14, 24, 25, 45) invariably develop viscerotropic disease after i.p. inoculation with MHV-3. Dupuy et al.
(4) and Levy-Leblond and Dupuy (14) have shown that in the absence of T-cell functions, an increased susceptibility to MHV-3 occurs in mice of the normally resistant A strain. These observations emphasize the interplay between hereditary and immunological factors influencing the disease processes caused by coronaviruses in rodents.
In this article we present additional comparative observations on the histopathology, serology, and influence of the immune state among rats and mice infected with either JHMV or MHV-3.
MATERIALS AND METHODS
Viruses and infection. The source of JHMV and MHV-3, the procedures used for propagating and assaying virus on L-2 murine fibroblasts, and the preparation of suspensions of these viruses for injection have been described previously (27) . Control animals were inoculated with a suspension of uninfected L-2 cells processed in the same manner as the virus inoculum. In i.c. inoculation of rats and mice, animals received 5 x 104 PFU of JHMV or 4 x 104 PFU of MHV-3. Mice injected i.p. received 3 x 105 PFU of JHMV or MHV-3 or 5 x 104 PFU of JHMV by intranasal (i.n.) inoculation.
All animals were monitored for clinical indications of neurological disease for 1 Mouse strains A/J, C57BL6/J, DBA/2, B6AF1 [(C57BL6/J x A/J)F1], and B6D2F1 [(C57BL6/J x DBA/2)F1] either 4 or 10 weeks of age were purchased from the Jackson Laboratory, Bar Harbor, Maine. Heterozygous C57 beige (bgl+) breeding pairs were purchased from Jackson Laboratory, and homozygous C57 beige mice (bglbg) were bred at our facility.
Likewise, male A/J and female DBA/2 mice were purchased from the Jackson Laboratory, and their Fl cross [(DBA/2 x A/J)F1] was bred at our facility. Adult RNC (nulnu) nude mice were purchased from 0. P. Miniats, Ontario Veterinary College, Guelph, Ontario, Canada.
Histology. All animals which either had succumbed to disease or had been killed were necropsied. Tissue samples were collected and processed for routine histopathological evaluation from all animals not showing evidence of autolysis, as described previously (27) . To achieve good fixation of the rat CNS, some animals were perfused with glutaraldehyde via the left ventricle, and the appropriate tissues were collected, cut into 1-mm cubes, postfixed, dehydrated, and embedded in epoxy resin (27) . Specimens were sectioned at 1-jum thickness for examination by light microscopy, and selected material was thin sectioned for examination in an electron microscope, according to our published procedure (27) . Additional material, including CNS, spleen, thymus, and liver tissue, was removed from mice, fixed by immersion in a solution of 3% glutaraldehyde in a 320 mosM phosphate buffer (27) , dehydrated, embedded in epoxy resin, and sectioned for light microscopic evaluation.
Immunosuppression studies. To test the effect of immunosuppression on survivors of the i.c. inoculation with JHMV, nine W/F rats which survived for 28 days beyond inoculation when 5 Fig. 1A .
Effectiveness of the immunosuppression regimen was confirmed by the absence of antibody responses to i.p. injection of SRBCs. Temporary abrogation of the immune response was demonstrated by the inability of sera from cyclophosphamide-treated animals to hemagglutinate SRBCs. However, rats immunized with SRBCs 5 weeks after the last cyclophosphamide infection did produce hemagglutinating antibodies with titers as high as those observed in untreated animals (data not shown).
Recovery of virus from infected rat CNS. Some rats inoculated i.c. with JHMV were without clinical symptoms of infection when killed up to 20 days p.i. However, JHMV was isolated from the brain tissue of all rats tested up to day 10 p.i. After longer incubation p.i., virus was isolated from the brains of rats only when the animals showed overt manifestations of neurological disease, in one case at 108 days p.i. Virus recovery was also made from the CNS of an affected rat after immunosuppression with cyclophosphamide. Tests showed that the isolated agent was indistinguishable from JHMV in 28-day-old C57BL6/J mice by morphology, in vitro cytopathology, or disease. These observations indicate that the virus can persist in the CNS for long periods after inoculation and in a small proportion of rats may cause demyelinating disease. In most rats made immunodeficient, CNS lesions were more extensive than previously observed and involved both grey matter lesions and demyelination.
Neutralizing antibodies in rats. Humoral immune responses were evaluated in sera from uninfected and JHMV-infected rats. All uninoculated animals tested possessed low levels of endogenous anti-JHMV antibodies, with the majority having endpoints (<90% plaque reduction) at dilutions of less than 1:10 (Table 2 ). This was interpreted to be due to the presence of antibodies to rat coronavirus, either sialodacryonadenitis virus or Parker's rat coronavirus. Indeed, clinical symptoms of sialodacryonadenitis virus infections were occasionally noted in both breeding and experimental animals. The crossreactivity of this virus with viruses of the MHV group has been well documented (21) . In general, serum antibody levels were not elevated after i.c. or i.p. inoculation of JHMV (Table 2) . Only 2 of 101 rats tested displayed titers higher than those noted among uninoculated controls, and these had relatively low titers (1:50 or 1:100) ( Table 2) . The presence or absence of circulating JHMV-neutralizing antibodies thus did not appear to affect the course of the disease observed in rats since survival was not correlated with an antibody response to the virus.
In general, the outcome of MHV infection in rats appears to be determined by the genetic (Table 3) . Fl crosses between A/J and DBA/2 or C57BL6/J mice failed to develop neurological disease during an observation period of more than 1 year (Table 3) . Nude mice, however, developed an acute fatal encephalomyelitis with focal hepatic necrosis after a relatively long incubation period (Table 3 ).
Among all strains tested, only nude mice were susceptible to infection with JHMV by i.n. inoculation (Table 3 ). The average survival time after exposure to virus i.n. was 9 days, an interval intermediate between that observed after i.c. infection (average, 5 days) and i.p. infection (Table 3 ). After i.n. inoculation, the grey matter of the olfactory bulbs and cerebrum was most severely damaged ( Fig. 2A and B) , where- Histological examination revealed lesions in the liver in two offour mice, in CNS grey matter in four of five mice, and in white matter in three of five mice.
as hepatic lesions (Fig. 2C ) and demyelinated lesions were less pronounced.
Contrary to the findings with rats, i.c. inoculation of MHV-3 into all mouse strains tested caused an acute, rapidly fatal encephalomyelitis with concurrent hepatic lesions. The mortality rate in all strains was 100%.
After i.p. injection of MHV-3, mice, including a significant fraction of B6AF1 mice, developed a fulminating fatal hepatitis (Table 4) . Our data on hybrid mice are at variance with those reporting a complete absence of fatal hepatitis among B6AF1 hybrids (13 (38) . Data on the yield of virus in culture fluids ( JHMV and MHV-3 were both more restricted in PM from the resistant A/J mice than in PM from the susceptible C57BL6/J strain ( Table 5 ). The in vitro data, especially those on MHV-3, support the hypothesis that susceptibility or resistance to i.p. infection is controlled by the efficiency of coronavirus replication in PM.
Protection of mice from CNS disease conferred by JHMV inoculation. Different genetically determined responses to MHV inoculation of rats and mice, documented in this and previous studies, led us to examine whether any other endogenous factors controlled susceptibility to the virus. Our approach was to challenge mice surviving after an initial JHMV infection i.p. by a second inoculation i.c. with a lethal dose of virus. A/J and C57BL6/J mice were reinoculated i.c. at specified intervals after the i.p. injection, and survivors were observed for an extended period. Both strains tested could be protected within 7 days by preinjection. However, the sparing effect became evident about 4 days sooner in C57BL6/J than in A/J mice ( (Table 2) , both commercially acquired and laboratory-bred mice frequently had low levels of circulating anti-JHMV antibodies (Table 7) . However, the seropositive uninoculated mice were infectable by either MHV-3 or JHMV develops, whereas progressive demyelination is associated with a chronic, progressive CNS disease (18, 27 (10, 28) . These studies revealed that the efficiency of virus replication in the neurons of SJL mice is controlled by a single gene locus (10) or perhaps two loci, one of which may be H-2 linked (28) .
On the other hand, MHV-3 usually elicits a viscerotropic disease when inoculated i.p. into mice but evokes no disease in rats. Genetic control of susceptibility or resistance to coronaviruses is amply documented by previous (13, 15, 39) and current findings. Resistance in mice of the A strain, which develops at about 10 weeks of age (12) , might be correlated with low efficiency of virus replication in PM. Among other strains, including C3H, A2G, and Fl crosses between resistant A and susceptible DBA/2 or C57BL6/J mice, partial age-related resistance also becomes evident by week 10 (14, 39) . Levy-Leblond et al. (15) have suggested that both the severity and the type of disease produced by MHV-3 in mice are controlled by two host genes, of which the recessive confers susceptibility to hepatitis and the other, linked to H-2, influences the development of a chronic CNS syndrome.
Current data and those of others (14) indicate (14, 27, 30, 43) . In rats, neurological disease follows one of two patterns regulated primarily by the genetic background and age of the animals rather than by the concentration of virus administered (27) . The acute form of disease is associated with extensive destruction of grey matter and rapid killing. Among animals surviving beyond day 21 p.i., the lesions developing in the optic nerve, rhombencephalon, and spinal cord are confined primarily to the white matter (27) . Foci of demyelination are probably caused by death of the oligodendrocytes, since JHMV has been demonstrated in these cells by electron microscopy and immunofluorescence (17, 27) .
In mice, myelinoclasis also appears to result from virally caused damage to and death of the oligodendrocytes (11, 20) . The nature of the disease may, in part, be related to the quantity of JHMV administered i.c. since high titers cause an acute, rapidly fatal encephalitis involving primarily the grey matter, whereas low titers provoke a more protracted encephalomyelitis characterized by damage to the white matter (21) . In mice, MHV infections are not confined to the CNS. Viscerotropic strains such as MHV-3, when inoculated i.p., cause extensive lesions, particularly in the liver, but also in the spleen, thymus, and lymph nodes (40) . In contrast, neither MHV-3 nor JHMV elicits any overt hepatic necrosis in rats (27) . However, in chronic JHMV infections of rats, involution of the thymus and spleen may also occur (1; 0. Sorensen, unpublished data).
Concerning age-related susceptiblity in rats, most strains are infectable i.c. with JHMV only during the first 2 weeks after birth, whereas mice remain susceptible for at least 1 year. Furthermore, i.p. infection of young mice with the neurotropic JHMV is possible (40) , but rats appear to be completely resistant to inoculation by this route (27) . Rats (14) , and X-irradiation (4) induce susceptibility to MHV among strains of mice naturally resistant to the virus. In the above experimental approaches, the T-cells appear to be a common factor controlling the outcome of the infectious process (14) . A detailed future analysis of T-cell activities after infection of genetically defined rats and mice offers a useful approach for elucidating the role of cellular immunity in the control of CNS disease produced by MHV. C57 beige (bglbg) mice have a partial impairment of natural killer (NK) cell functions (2, 9, 16) without alteration in activities of their B-or T-cells involved in humoral or cellular immunity (21, 22, 23) . The normal response to JHMV infection in these mice indicates that the lack of the killing activity of NK cells does not influence the outcome of CNS disease in mice. On the other hand, nude mice, possessing an elevated NK cell response (42) , are highly susceptible to JHMV infection, as the present study demonstrates.
The onset of age-related resistance to MHV-3 is clearly evident in A/J mice, which remain infectable i.p. for about 10 weeks after birth. The capacity for conferring resistance to young A/J mice is associated with spleen cells of adults which, upon injection, provide protection 35, 37) . Such protection has been ascribed to the cotransfer of T-lymphocytes and an adherent spleen cell (14) and to an NK-like cell designated M (35) . Data on C57 beige mice presented here suggest that if the Mcell is an NK cell, its killing function is not essential for its role in resistance.
Similar protection against i.c. infection with JHMV can be accomplished by transferring from adults to 6-week-old SJL mice the adherent spleen cells (29) , again implying a protective function for macrophages. The role of macrophages in the control of coronavirus disease among resistant A/J and other mice may be related to inefficient replication and low virus yields demonstrated by in vitro and in vivo studies reported here and previously (2, 8, 26, 37, 38) . Thus, production of limited quantities of virus by the initial target host cell might allow sufficient time for the induction of the appropriate immunological responses required for suppressing the infection. A correlation between the low rate of MHV production and the resistance of A/J mice to disease also holds in substrains of C3H mice infected i.p. with the PRI strain of MHV (26) . The control of virus production in macrophages has been ascribed to soluble factors such as lymphokines (36) and could also involve hormonal regulation by the corticosteroids (44). It is not known whether the lymphokines are IF or IF-like substances.
As to the influence of humoral immunity, endemic infection of rats by rat coronavirus (3, 19) , an agent serorelated to the MHV group (21), commonly occurs. Likewise, asymptomatic infections of laboratory rodents with MHV may occur (6, 31) , making the interpretation of the role of circulating antibodies in the CNS disease pattern somewhat ambiguous. However, the current data provide no evidence to support the idea that neutralizing antibodies in the circulation in any way alter the disease process in the CNS of rats inoculated i.c. Also, mice first inoculated i.p. with JHMV are protected against an i.c. challenge before elevated humoral antibodies appear. These observations coincide with the findings on reinfection with another strain in this virus group, MHV-S, in mice as reported by Taguchi et al. (33) , who ascribed the early protection to rapid sensitization of macrophages, the cell type shown to provide an initial defense in nude mice challenged i.p. with MHV (34) .
One possible factor involved in early protection is IF. Evidence to this effect was provided by Verilizier and Gresser (40) , who were able to suppress i.p. infection with MHV-3 by IF and to abrogate the inhibition with anti-IF antiserum. In contrast, our present analyses, albeit limited in scope, did not reveal elevation in circulating IF after i.p. inoculation of JHMV into mice, nor did they reveal any correlation between IF levels and the rapid onset of protection in C57BL6/J mice. Further analysis of this phenomenon would be appropriate to resolve the apparent discrepancy. In another study, Taguchi et al. (32) demonstrated a correlation in mice between age-dependent resistance to MHV-3 replication in PM and increased IF levels, a result consistent with the observed capacity of anti-IF antibodies to increase the severity of MHV-3 infection (40) . However, since the natural resistance of A-strain mice to coronavirus infection could not be reversed by the injection of anti-IF antibody, the possibility remains that low levels of circulating IF during the chronic phase of infection by MHV-3 lead to the development of an immunosuppressed state (41), thereby increasing susceptibility to disease produced by the virus.
In summary, previous and current observations demonstrate that infection of rats and mice by MHV, producing a spectrum of CNS diseases, provides suitable models for continued investigation of the factors controlling latency, persistence, and demyelination. W/F rats appear to be particularly useful for investigating progressive demyelination, since with this strain a predictably high morbidity can be achieved. To achieve a better understanding of factors involved in the development of chronic progressive demyelination long after the initial infection has occurred, future studies might profitably focus on such parameters as the age-related and genetically controlled development of resistance to infection and the control of virus persistence in the CNS.
